ENTRAPMENT OF BETA-LACTAMS ANTIBIOTICS IN POLYETHYLCYANOACRYLATE NANOPARTICLES - STUDIES ON THE POSSIBLE IN-VIVO APPLICATION OF THIS COLLOIDAL DELIVERY SYSTEM

被引:38
作者
CAVALLARO, G
FRESTA, M
GIAMMONA, G
PUGLISI, G
VILLARI, A
机构
[1] UNIV CATANIA,IST CHIM FARMACEUT & TOSSICOL,I-95125 CATANIA,ITALY
[2] UNIV PALERMO,DIPARTIMENTO CHIM & TECNOL FARMACEUT,I-90123 PALERMO,ITALY
[3] ETH ZURICH,INST POLYMERE,CH-8092 ZURICH,SWITZERLAND
[4] UNIV MESSINA,DIPARTIMENTO FARMACOCHIM,I-98100 MESSINA,ITALY
关键词
POLYETHYLCYANOACRYLATE; NANOPARTICLE; BETA-LACTAM; CEFSULODIN; CEFACLOR; RELEASE; MEMBRANE PERMEABILITY;
D O I
10.1016/0378-5173(94)90399-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polyethylcyanoacrylate (PECA) nanoparticles were prepared in the presence of three different non-ionic surfactants: Triton X-100, Tween 80 and Pluronic F68. The influence of the surfactant, employed during the nanoparticle preparation process, on drug loading, size and storage stability was evaluated. The amount of Cefaclor (CFR) and Cefsulodin (CFN) entrapped in the colloidal system was not influenced by the presence of the three different surfactants, achieving a mean loading value of about 1.6% (w/w). PECA nanoparticles prepared in the presence of Tween 80 and Pluronic F68 and entrapping the two drugs showed no dependence of the mean particle size on the various components present in the polymerization medium. Only the system obtained in the presence of Triton X-100 showed an increase in particle size compared to the nanoparticles prepared in the absence of the active compound. Storage at room temperature, as dried powder, caused a drastic increase in size and polydispersity index values of the PECA nanoparticles containing CFN or CFR. The PECA nanoparticle colloidal suspensions prepared in the presence of Pluronic F68 provided much greater values of the retention capability for CFN and CFR, followed by the systems prepared in the presence of Tween 80 and Triton X-100, respectively. For each nanoparticle formulation, the retention of CFR was higher than that of CFN. The permeability through a biological membrane model was greater for CFN loaded nanoparticles than for the free drug. In contrast, no noticeable difference was observed between free CFR and that loaded in PECA nanoparticles, prepared with Pluronic F68 or Triton X-100. Only the system prepared in the presence of Tween 80 showed a high diffusion rate of CFR compared to the free drug.
引用
收藏
页码:31 / 41
页数:11
相关论文
共 33 条
  • [1] APPROACHES TO IMPROVE THE ASSOCIATION OF AMIKACIN SULFATE TO POLY(ALKYLCYANOACRYLATE) NANOPARTICLES
    ALONSO, MJ
    LOSA, C
    CALVO, P
    VILAJATO, JL
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 68 (1-3) : 69 - 76
  • [2] FREE VERSUS LIPOSOME-ENTRAPPED AMPICILLIN IN TREATMENT OF INFECTION DUE TO LISTERIA-MONOCYTOGENES IN NORMAL AND ATHYMIC (NUDE) MICE
    BAKKERWOUDENBERG, IAJM
    LOKERSE, AF
    ROERDINK, FH
    REGTS, D
    MICHEL, MF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (05) : 917 - 924
  • [3] CORNEA PREPARATION FOR INVITRO BIOPHARMACEUTICAL EVALUATION OF OPHTHALMIC DOSAGE FORMS
    BARRELET, J
    TSACOPOULOS, M
    BURI, P
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (12) : 919 - 922
  • [4] INFLUENCE OF POLYBUTYLCYANOACRYLATE NANOPARTICLES AND LIPOSOMES ON THE EFFICACY AND TOXICITY OF THE ANTICANCER DRUG MITOXANTRONE IN MURINE TUMOR-MODELS
    BECK, P
    KREUTER, J
    RESZKA, R
    FICHTNER, I
    [J]. JOURNAL OF MICROENCAPSULATION, 1993, 10 (01) : 101 - 114
  • [5] BUDAVARI S, 1989, MERCK INDEX, P293
  • [6] ADSORPTION OF ETHOXYLATED SURFACTANTS ON NANOPARTICLES .1. CHARACTERIZATION BY HYDROPHOBIC INTERACTION CHROMATOGRAPHY
    CARSTENSEN, H
    MULLER, BW
    MULLER, RH
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 67 (01) : 29 - 37
  • [7] POLYALKYLCYANOACRYLATE NANOPARTICLES AS DRUG CARRIER - PRESENT STATE AND PERSPECTIVES
    COUVREUR, P
    VAUTHIER, C
    [J]. JOURNAL OF CONTROLLED RELEASE, 1991, 17 (02) : 187 - 198
  • [8] TISSUE DISTRIBUTION OF ANTI-TUMOR DRUGS ASSOCIATED WITH POLYALKYLCYANOACRYLATE NANOPARTICLES
    COUVREUR, P
    KANTE, B
    LENAERTS, V
    SCAILTEUR, V
    ROLAND, M
    SPEISER, P
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (02) : 199 - 202
  • [9] DASGUPTA V, 1984, J CLIN HOSP PHARM, V9, P21
  • [10] Davis S. S., 1984, MICROSPHERES DRUG TH